Citigroup »

Esperion Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 381k 3.00
2023-09-30 $15k 15k 0.98
2023-03-31 $64k 40k 1.59
2022-12-31 $98k 16k 6.23
2022-09-30 $87k 13k 6.67
2021-12-31 $73k 15k 4.99
2021-03-31 $4.6M 165k 28.05
2020-12-31 $1.7M 64k 26.12
2020-09-30 $2.5M 67k 37.19
2020-06-30 $4.3M 84k 51.37
2020-03-31 $2.1M 66k 31.55
2019-12-31 $5.0M 85k 59.71
2019-09-30 $5.5M 151k 36.66
2019-06-30 $9.6M 206k 46.51
2019-03-31 $2.5M 62k 40.10
2018-12-31 $13M 288k 46.03
2018-09-30 $6.6M 148k 44.38
2018-06-30 $3.0M 77k 39.19
2018-03-31 $2.9M 40k 72.41
2017-12-31 $5.3M 80k 65.84
2017-09-30 $2.5M 50k 50.13
2017-06-30 $3.7M 80k 46.29
2017-03-31 $1.6M 44k 35.30
2016-12-31 $343k 27k 12.54
2016-09-30 $388k 28k 14.00
2016-06-30 $310k 31k 10.00
2015-12-31 $919k 46k 20.00
2015-09-30 $762k 32k 23.55
2015-06-30 $1.8M 22k 80.81
2014-09-30 $415k 19k 21.43
2014-03-31 $284k 19k 15.12
2013-12-31 $262k 19k 13.57
2013-09-30 $200k 11k 18.86